Cargando…
P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621497/ http://dx.doi.org/10.1097/01.HS9.0000890600.53871.dd |
| _version_ | 1784821569731690496 |
|---|---|
| author | Voltin, Conrad-Amadeus Kreissl, Stefanie Kaul, Helen Bühnen, Ina Mettler, Jasmin Pabst, Thomas Eichenauer, Dennis A. Fuchs, Michael Diehl, Volker Dietlein, Markus Engert, Andreas Borchmann, Peter Kobe, Carsten |
| author_facet | Voltin, Conrad-Amadeus Kreissl, Stefanie Kaul, Helen Bühnen, Ina Mettler, Jasmin Pabst, Thomas Eichenauer, Dennis A. Fuchs, Michael Diehl, Volker Dietlein, Markus Engert, Andreas Borchmann, Peter Kobe, Carsten |
| author_sort | Voltin, Conrad-Amadeus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621497 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96214972022-11-01 P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma Voltin, Conrad-Amadeus Kreissl, Stefanie Kaul, Helen Bühnen, Ina Mettler, Jasmin Pabst, Thomas Eichenauer, Dennis A. Fuchs, Michael Diehl, Volker Dietlein, Markus Engert, Andreas Borchmann, Peter Kobe, Carsten Hemasphere Advanced Stages Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621497/ http://dx.doi.org/10.1097/01.HS9.0000890600.53871.dd Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Advanced Stages Voltin, Conrad-Amadeus Kreissl, Stefanie Kaul, Helen Bühnen, Ina Mettler, Jasmin Pabst, Thomas Eichenauer, Dennis A. Fuchs, Michael Diehl, Volker Dietlein, Markus Engert, Andreas Borchmann, Peter Kobe, Carsten P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma |
| title | P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma |
| title_full | P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma |
| title_fullStr | P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma |
| title_full_unstemmed | P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma |
| title_short | P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma |
| title_sort | p008: impact of bone marrow involvement on early pet response and progression-free survival in the hd18 trial for patients with advanced-stage hodgkin lymphoma |
| topic | Advanced Stages |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621497/ http://dx.doi.org/10.1097/01.HS9.0000890600.53871.dd |
| work_keys_str_mv | AT voltinconradamadeus p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT kreisslstefanie p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT kaulhelen p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT buhnenina p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT mettlerjasmin p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT pabstthomas p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT eichenauerdennisa p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT fuchsmichael p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT diehlvolker p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT dietleinmarkus p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT engertandreas p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT borchmannpeter p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma AT kobecarsten p008impactofbonemarrowinvolvementonearlypetresponseandprogressionfreesurvivalinthehd18trialforpatientswithadvancedstagehodgkinlymphoma |